Accordingly, some PDE inhibitors (PDE2A, PDE3, PDE4/4D, and PDE10A) have been proposed to treat neurodevelopmental diseases, including ASD and FXS [21, 22, 27]. The gene discussed is PDE4A; the disease is fragile X syndrome.